HomeCompareMRK vs ABBV

MRK vs ABBV: Dividend Comparison 2026

MRK yields 3.25% · ABBV yields 3.67% · See full DRIP projection below

vsEnter any two US tickers
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $9.2K in total portfolio value
10 years
MRK
Merck & Co. Inc.
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →
ABBV
AbbVie Inc.
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — MRK vs ABBV

Annual dividend income

MetricMRKABBV
Forward yield3.25%3.67%
Annual dividend / share$3.08$6.20
Payout ratio42%58%
1-year div growth5.5%4.7%
5-year div CAGR8.2%8.9%
Portfolio after 10y$30.7K$39.9K
Annual income after 10y$950.29$1,154.43
Total dividends collected$6.1K$7.2K
Payment frequencyquarterlyquarterly
SectorHealthcareHealthcare

Year-by-year: MRK vs ABBV ($10,000, DRIP)

YearMRK PortfolioMRK Income/yrABBV PortfolioABBV Income/yrGap
1$11,192$351.54$11,520$399.75$328.00ABBV
2$12,524$392.70$13,261$450.98$737.00ABBV
3$14,015$438.65$15,255$508.41$1.2KABBV
4$15,682$489.96$17,536$572.74$1.9KABBV
5$17,547$547.23$20,145$644.78$2.6KABBV
6$19,632$611.16$23,126$725.38$3.5KABBV
7$21,963$682.53$26,532$815.52$4.6KABBV
8$24,571$762.18$30,420$916.26$5.8KABBV
9$27,486$851.08$34,855$1,028.80$7.4KABBV
10$30,745$950.29$39,914$1,154.43$9.2KABBV

MRK vs ABBV: Complete Analysis 2026

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

Frequently Asked Questions

Is MRK or ABBV better for dividend income in 2026?
MRK currently offers a 3.25% yield (3.08/share/year) while ABBV offers 3.67% (6.20/share/year). ABBV provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs ABBV earn per year?
With $10,000 invested today: MRK pays approximately $325/year. ABBV pays approximately $367/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $1,154/year (ABBV).
Does MRK or ABBV pay monthly dividends?
MRK pays quarterly dividends. ABBV pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬

Get this MRK vs ABBV comparison by email

Save your analysis + get weekly dividend insights. Free forever.

More comparisons

MRK vs JNJMRK vs PFEMRK vs BMYMRK vs LLYABBV vs JNJABBV vs MRKABBV vs PFEABBV vs BMY

⚠️ Educational purposes only. Not financial advice. All projections use historical data; actual results will vary.